IRIS
COGNIGNI, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 378
EU - Europa 137
AS - Asia 58
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 378
IT - Italia 73
CN - Cina 33
IE - Irlanda 25
SG - Singapore 22
CI - Costa d'Avorio 18
SE - Svezia 11
MA - Marocco 10
FR - Francia 7
AT - Austria 5
GB - Regno Unito 4
BE - Belgio 3
DE - Germania 3
FI - Finlandia 3
IN - India 3
AU - Australia 1
EU - Europa 1
NL - Olanda 1
RU - Federazione Russa 1
UA - Ucraina 1
VE - Venezuela 1
Totale 604
Salva come PNG Salva come JPEG
Città #
Chandler 46
Des Moines 37
Fairfield 34
Boardman 30
Ashburn 26
Dublin 21
Ancona 20
Wilmington 19
Abidjan 18
Cambridge 17
New York 16
Seattle 16
Woodbridge 16
Houston 11
Singapore 9
Turin 7
Ann Arbor 6
Guangzhou 5
Lawrence 5
Los Angeles 5
Princeton 5
Redmond 5
Tolentino 5
Washington 5
Arnold 4
Macerata 4
Milan 4
San Diego 4
Vienna 4
Xi'an 4
Brussels 3
Helsinki 3
Pune 3
San Mateo 3
Wuhan 3
Beijing 2
Cantu 2
Falconara Marittima 2
Ningbo 2
Orange 2
Parma 2
Zhengzhou 2
Amsterdam 1
Boston 1
Brandenburg 1
Centro 1
Chicago 1
Chiswick 1
Dallas 1
Genzano di Roma 1
Hangzhou 1
Huizhou 1
Jacksonville 1
Jiaxing 1
Kilburn 1
London 1
Mantova 1
Norwalk 1
Phoenix 1
Qingdao 1
Saint Petersburg 1
Santa Clara 1
Wuxi 1
Zibo 1
Totale 459
Salva come PNG Salva come JPEG
Nome #
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy 172
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 76
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 71
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 56
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 50
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 40
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 34
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study 32
NSCLC-Pro ClustAI: A Machine Learning Model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 28
Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma 23
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives 21
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 20
Totale 623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 52 50 1 0 3 1 2 7 3
2021/202262 0 3 0 0 15 5 5 2 8 3 9 12
2022/2023176 11 13 6 11 7 45 0 5 23 4 42 9
2023/2024154 24 3 10 10 15 36 2 1 0 6 3 44
2024/2025112 64 25 23 0 0 0 0 0 0 0 0 0
Totale 623